Home > Insider Trading > Filing (0001127602-21-001603)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
64803	Cvs Health Corp	CVS	Retail-Drug Stores And Proprietary Stores (5912)	050494040

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1479663	Lisa Bisaccia	One Cvs Drive Woonsocket RI 02895	Evp And Chief Hr Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-01-12	25,177	$74.29	71,765	No	4	M	Direct
Common Stock	Disposition	2021-01-12	25,177	$77.00	46,588	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2021-01-12	25,177	$0.00	25,177	$74.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2015-04-01	2021-04-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock (Restricted)	6,147	Direct
Esop Common Stock	634	Indirect	Direct
Stock Unit	32,020	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Phantom Stock Credits	$1.00			469	469	Direct
Common Stock	Stock Option	$102.26	2016-04-01	2022-04-01	34,241	34,241	Direct
Common Stock	Stock Option	$104.82	2017-04-01	2023-04-01	39,433	39,433	Direct
Common Stock	Stock Option	$78.05	2018-04-03	2024-04-03	55,098	55,098	Direct
Common Stock	Stock Option	$62.21	2019-04-01	2025-04-01	64,222	64,222	Direct
Common Stock	Stock Option	$54.19	2020-04-01	2029-04-01	141,405	141,405	Direct
Common Stock	Stock Option	$58.34	2021-04-01	2030-04-01	98,558	98,558	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	469	469	Direct
2022-04-01	34,241	34,241	Direct
2023-04-01	39,433	39,433	Direct
2024-04-03	55,098	55,098	Direct
2025-04-01	64,222	64,222	Direct
2029-04-01	141,405	141,405	Direct
2030-04-01	98,558	98,558	Direct

Footnotes

All sales were effected pursuant to a Rule 10b5-1 plan.
Option became exercisable in four equal annual installments, commencing 4/1/2015.
Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
Option became exercisable in four equal annual installments, commencing 4/1/2016.
Option became exercisable in four equal annual installments, commencing 4/1/2017.
Option became exercisable in four equal annual installments, commencing 4/3/2018.
Option became exercisable in four equal annual installments, commencing 4/1/2019.
Option became exercisable in four equal annual installments, commencing 4/1/2020.
The number of shares subject to the option were calculated using a 30-day average price.
Option becomes exercisable in four equal annual installments, commencing 4/1/2021.